Clinical Trial

A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease

Completed Phase 2
View on ClinicalTrials.gov →
Summary
A 4-Week, Randomized, Double-Masked, Parallel-Group, Active-Controlled, Multicenter Study Evaluating Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination Administered Twice Daily on Signs and Symptoms of Dry Eye Disease
Protocol Amendment History 3 changes
critical Trial completed 2026-07-15
notable Primary completion moved earlier: 2026-11 -> 2026-05-28 2026-07-15
minor Completion moved earlier: 2026-11 -> 2026-05-28 2026-07-15
Trial Details
NCT Number NCT07128628
Lead Sponsor Bausch & Lomb Incorporated
Conditions Dry Eye Disease
Enrollment 443 participants
Start Date 2025-10-24
Primary Completion 2026-05-28 (estimated)
Study Completion 2026-05-28 (estimated)
Updated on ClinicalTrials.gov 2026-07-14